Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2007
11/08/2007US20070259389 Photoproteins With Enhanced Bioluminescence And Assays Using The Same
11/08/2007US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007US20070259379 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity
11/08/2007US20070259378 For drug screening; competitive binding; measuring activation by measuring [Ca2+] in the mixture
11/08/2007US20070259374 In vitro sorting method
11/08/2007US20070259372 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/08/2007US20070259364 DETECTION OF METHYLATED CpG RICH SEQUENCES DIAGNOSTIC FOR MALIGNANT CELLS
11/08/2007US20070259362 Testing stability of fluorescent probes; diagnostic reporters for genic analysis
11/08/2007US20070259358 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases
11/08/2007US20070259354 Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators
11/08/2007US20070259342 Lymphoma associated molecules and uses therefor
11/08/2007US20070259087 Antimicrobial Peptides
11/08/2007US20070259004 Expression vector for Bacillus species
11/08/2007US20070259003 Clostridial toxin derivatives and methods for treating pain
11/08/2007US20070258999 Sars Virus Nucleotide and Amino Acid Sequences and Uses Thereof
11/08/2007US20070258997 Rescue of mumps virus from CDNA
11/08/2007US20070258994 Immunomodulatory formulations and methods for use thereof
11/08/2007US20070258993 Dna-Carrier Conjugate
11/08/2007US20070258985 Human mini-antibody cytotoxic for tumor cells which express the ERB-B2 receptor
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258978 Immunogenic Recombinant Antibody
11/08/2007US20070258968 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells
11/08/2007US20070258962 Plasmid comprising murine cytomegalovirus intermediate early 2 (mCMV-IE2) promoter for enhancing heterologous gene transcription; gene therapy and genetic engineering
11/08/2007US20070258955 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/08/2007US20070258954 Directed evolution of enzymes and antibodies
11/08/2007US20070258952 Anti-Tumor Activity of an Oncolytic Adenovirus-Delivered Oncogene siRNA
11/08/2007US20070258951 Methods of treating cardiac disorders
11/08/2007US20070258949 Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use
11/08/2007US20070258948 Tissue Modeling in Embryonic Stem (Es) Cell System
11/08/2007US20070258944 Multiple cytokine protein complexes
11/08/2007US20070258904 Optical Imaging Contrast Agents
11/08/2007US20070258901 Capsules Containing Transiently Transfected Cells, Method for Preparing Same and Uses Thereof
11/08/2007DE102006021722A1 Oligonucleotide probes for detecting Erwinia amylovora in a sample by in situ hybridization are complementary to a segment of an Erwinia amylovora 16S ribosomal RNA coding sequence
11/08/2007DE102006021516A1 Gen-Konversionskonstrukt und Verfahren zur Vererbung von Genmobilität sowie Verwendung des Konstrukts Gene conversion construct and procedures for inheritance of Genmobilität and use of the construct
11/08/2007DE102006020148A1 Gentechnisch hergestelltes Perlucin und seine Verwendung zur Herstellung von Biomaterialien Perlucin genetically engineered and its use for the preparation of biomaterials
11/08/2007DE10054303B4 Analoga, Agonisten, Antagonisten und Varianten der Oxidoreduktase-Enzymaktivität des Makrophagen-Migrations-Inhibitions-Faktors (MIF) als Immunmodulatoren, Therapeutika, Diagnostika und Screening-Agenzien bei inflammatorischen und Immunerkrankungen Analogues, agonists, antagonists, and variants of the oxidoreductase enzyme activity of macrophage migration inhibitory factor (MIF) as immunomodulators, therapeutic agents, diagnostic and screening agents in inflammatory and immune diseases
11/08/2007CA2682320A1 An animal model and a method for producing an animal model
11/08/2007CA2651180A1 Methods and compounds to alter virus infection
11/08/2007CA2651031A1 Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease
11/08/2007CA2650810A1 Thermostable cellulase and methods of use
11/08/2007CA2650768A1 Genetic system for controlling the floral development of a dicotyledonous plant, and use thereof in detection and selection processes
11/08/2007CA2650685A1 Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
11/08/2007CA2650594A1 Adipose derived adult stem cells in hepatic regeneration
11/08/2007CA2650380A1 Monoclonal antibodies and their use
11/08/2007CA2650375A1 Genetic adjuvants for viral vaccines
11/08/2007CA2650270A1 High-titer retroviral packaging cells
11/08/2007CA2649871A1 Disease-inducible promoters
11/08/2007CA2648086A1 Methods and compositions for inducing an immune response to hiv and models for testing
11/08/2007CA2648067A1 Cancer immunotherapy compositions and methods of use
11/08/2007CA2647985A1 High titer recombinant influenza viruses for vaccines
11/08/2007CA2646129A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids
11/08/2007CA2646048A1 Compositions and methods of use for antibodies of c-met
11/07/2007EP1852511A1 Bovine immunodeficiency virus (biv) based vectors
11/07/2007EP1852510A1 5-substituted hydantoin racemase, dna encoding the same, recombinant dna, transformed cell, and process for production of optically active n-carbamylamino acid or optically active amino acid
11/07/2007EP1852508A2 Actinomycetes polynucleotides
11/07/2007EP1852507A1 CRSP protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
11/07/2007EP1852506A2 Lipophilic derivatives of double-stranded ribonucleic acid
11/07/2007EP1852505A1 Mutations in ion channels
11/07/2007EP1852504A1 Preparation of calibrants and their application of useful nucleotide sequences
11/07/2007EP1852503A1 Il-13 production inhibitor
11/07/2007EP1852442A1 Antibody for assay of adamts13 activity and method of activity assay
11/07/2007EP1852440A1 Alpha-conotoxin peptides
11/07/2007EP1852125A2 Neisserial vaccine compositions and methods
11/07/2007EP1852124A1 Fibrosis inhibitor for implanted organ
11/07/2007EP1852123A2 Activation and inhibition of the immune system
11/07/2007EP1851337A2 Dnd purification and analysis on nanoengineered surfaces
11/07/2007EP1851321A2 Hiv epitopes and pharmaceutical composition containing same
11/07/2007EP1851320A1 Vaccines based on the use of mva
11/07/2007EP1851319A1 Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
11/07/2007EP1851318A2 Expression cassettes for regulation of expression in monocotyledonous plants
11/07/2007EP1851317A1 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
11/07/2007EP1851316A1 Means for obtaining avirulent leishmania promastigotes, promastigotes obtained, and the applications thereof
11/07/2007EP1851315A1 Human antibodies against rabies and uses thereof
11/07/2007EP1851314A2 Immunostimulatory oligonucleotides
11/07/2007EP1851313A1 Method for isolating nucleic acids, the nucleic acids being immobilised on a matrix at an increased temperature
11/07/2007EP1851312A2 Mutant aox 1 promoters
11/07/2007EP1851310A2 Crystal structure of tak1-tab1
11/07/2007EP1851309A2 Altered isopenicillin-n acyltransferase polypeptides and related polynucleotides
11/07/2007EP1851307A1 Method of treatment by administration of rna
11/07/2007EP1851302A1 Cartridge retaining mechanism for nucleic acid extracting apparatus
11/07/2007EP1851242A2 Novel egg receptors for sperm proteins
11/07/2007EP1851240A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
11/07/2007EP1851239A1 Replication-deficient rna viruses as vaccines
11/07/2007EP1851238A2 Influenza nucleic acids, polypeptides, and uses thereof
11/07/2007EP1850959A2 Containers for liquid storage and delivery with application to microfluidic devices
11/07/2007EP1850880A2 Aptamer therapeutics useful in the treatment of complement-related disorders
11/07/2007EP1850869A2 Nucleic acid constructs
11/07/2007EP1850868A2 Oral vaccines for fish
11/07/2007EP1850659A2 Transgenic chickens
11/07/2007EP1850656A2 Genes and uses for plant improvement
11/07/2007EP1791975A4 Compositions and methods for phage display of polypeptides
11/07/2007EP1651684B1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions
11/07/2007EP1642977B1 Gene involved in growth-promoting function of acetic acid bacteria and uses thereof
11/07/2007EP1639081A4 Compositions and methods for regulating polysaccharides of a plant cell
11/07/2007EP1565578A4 Rnai-based sensors, caged interfering rnas, and methods of use thereof
11/07/2007EP1520010B1 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation
11/07/2007EP1490682B1 Detection of dna-binding proteins
11/07/2007EP1461437B1 Expression vectors and promoters for heterologous gene expression
11/07/2007EP1446475A4 RECOMBINANT DNA PROCESSES USING A dNTP MIXTURE CONTAINING MODIFIED NUCLEOTIDES
11/07/2007EP1423707B1 Methods of screening molecules that are used to prevent cardiovascular diseases